Clinical Trial Update: High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial Fibrillation (NVAF) in France

View source ↗

Summary

Clinical trial update reporting high gastrointestinal bleed risk outcomes in patients with non-valvular atrial fibrillation (NVAF) in France.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Pfizer | Conditions: Atrial Fibrillation | Status: ACTIVE_NOT_RECRUITING